Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefixime (200mg) + Dicloxacillin (500mg) + Lactic Acid Bacillus (90Million Spores) Tablet
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cefixime (200mg) + Dicloxacillin (500mg) + LB is a high-profit product built for our PCD Pharma Franchise partners.
This high-strength, dual-antibiotic combination is fortified with Lactic Acid Bacillus (LB). It's a top clinical necessity that maximizes sales revenue.
Why this High-Potency Composition is Your Key to Profit:
High Demand, Superior Strength: The 200mg/500mg mix targets tough, resistant infections. Doctors need this strength, which guarantees consistent, high sales volume for you.
LB Stops Side Effects: The LB ensures better patient comfort and compliance by preventing antibiotic diarrhea. This builds doctor loyalty and secures repeat orders.
Maximum Profit: Positioned as a strong, premium combination, this formula allows for excellent pricing and the highest profit margins in the fast-moving anti-infective segment.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition. Partner with us for full marketing support and reliable supply to turn this essential drug into guaranteed business growth.
Contact us today to secure this high-margin territory!
May include diarrhea, nausea, abdominal pain, and potential allergic reactions.
Treatment of bacterial infections such as respiratory and urinary tract infections.
Consult your healthcare provider before use, especially if you have a history of allergies to antibiotics.
Store in a cool, dry place away from direct sunlight.
Composition : Cefpodoxime Proxetil (100mg)
Composition : Cefpodoxime Proxetil (200mg)
Composition : Cefpodoxime Proxetil (200mg) + Clavulanic Acid (125mg)
Composition : Cefpodoxime Proxetil (200mg) + Ofloxacin (200mg)
Composition : Cefuroxime (250mg)
Composition : Cefuroxime (500mg)
Composition : Cefuroxime (500mg) + Clavulanic Acid (125mg)
Composition : Cephalexin (125mg) DT
Composition : Cephalexin (750mg) ER
Composition : Cephalexin (250mg) DT
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the advanced antibiotic and gut health segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the growing demand for this formulation in bacterial infections with probiotic support to reduce antibiotic-associated side effects. Including this product helps strengthen their antibiotic + gut health portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for this combination tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted antibiotic-probiotic combination range when partnering with Cafoli Lifecare for this formulation.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this product can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.